There are around 12,100 people diagnosed with a tumour in the brain or central nervous system (CNS) each year in the UK. Brain and spinal cord tumours can affect children and adults and common symptoms include headaches, feeling or being sick and seizures (fits).
We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
‘The word ‘legacy’ is often overused, but not about the late Baroness Tessa Jowell’. Michelle Mitchell reflects on Cancer Research UK’s new brain tumour funding.
Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research.
Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.
Potential new drug targets for an aggressive type of brain tumour have been uncovered in the lab, thanks to a ‘reverse engineering’ approach using DNA editing.
Our scientists have shown it’s possible to detect brain tumour DNA in the liquid surrounding the brain using a cheap technique.
Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine.
We look at why researchers are working towards brain tumour treatments that are not only more effective, but also kinder.